SEngine Precision Medicine

About:

SEngine Precision Medicine uses algorithms and 3D organoid technology to develop drugs with more efficacy.

Website: https://senginemedicine.com

Twitter/X: SEngineMedicine

Top Investors: National Institutes of Health, Washington Research Foundation, Vincere Capital, Alethea Capital Management, Bangarang Group

Description:

SEngine Precision Medicine uses algorithms and 3D organoid technology to develop drugs with more efficacy. It empowers patients and oncologists with more informed treatment options. The company's technology simultaneously tests more than 200 cancer drugs against a patient's unique tumor organoid outside the body. The results decode the most effective and least toxic treatment options that DNA sequencing alone cannot reveal. Its proprietary platform leverages the aggregated, anonymized test results to develop new cancer-fighting drugs.